2004 News Archive

Morphotek Appoints Senior Vice President of Clinical Development to Advance Therapeutic Antibody Portfolio

December 21, 2004

Morphotek Inc. announced today the appointment of Martin D. Phillips, M.D., as Senior Vice President of Clinical Development. Dr. Phillips has been...

+ Read the Article

Morphotek Issued U.U. Patent 6,825,038 for Generating Genetically Evolved Mammalian Cells Through the Regulation of Mismatch Repair

December 13, 2004

Morphotek Inc. announced today the issuance of United States Patent 6,825,038 covering the regulation of mismatch repair (MMR), a powerful process...

+ Read the Article

Morphotek Announces Second Research Collaboration and License Agreement with Novo Nordisk to Develop High-Titer Cell Lines for the Scaleable Manufacturing of Therapeutic Antibodies

December 1, 2004

Morphotek Inc. today announced that it has entered into a multi-product Research Collaboration and License Agreement with Novo Nordisk (NYSE: NVO)...

+ Read the Article

Morphotek Honored With Technology Company of the Year Award

November 17, 2004

Morphotek Inc. announced today that it has been named “2004 Technology Company of the Year” by the Greater Philadelphia Chamber of...

+ Read the Article

Morphotek and SC BioSciences Announce a Business Collaboration for the Marketing of Morphotek's Proprietary Cell Line Evolution Services in Japan

November 15, 2004

Morphotek Inc. and SC BioSciences (SCB) today announced a business collaboration agreement in which SCB will serve as the Japanese marketing partner...

+ Read the Article

Morphotek Issued U.S. Patent for Generating Genetically Altered Antibody Producing Cell Lines With Improved Antibody Characteristic

November 8, 2004

Morphotek Inc. announced today the issuance of United States Patent 6,808,894 covering the generation of genetically enhanced antibody producer cell...

+ Read the Article

Morphotek Announces Collaborative Agreement with Tanox to Develop High-Titer Production Cells for the Manufacturing of Therapeutic Antibodies Using Suppressor of Immunoglobulin Product (SIP) Technology

November 7, 2004

Morphotek Inc. announced today that it has signed a collaborative research agreement with Tanox, Inc. (NASDAQ: TNOX) of Houston, TX, for the use of...

+ Read the Article

Morphotek Announces Research and Development Agreement with USAMRID at Fort Detrick for the Development of Antibodies to Detect and Treat Biowarfare Pathogens

September 27, 2004

Morphotek Inc. announced today that it has signed a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical...

+ Read the Article

Morphotek Signs Development and Clinical Supply Agreement with Baxter for Lead Therapeutic Antibody

August 10, 2004

Morphotek Inc. announced today that it has entered into an agreement for Baxter Healthcare Corporation to support the development and manufacture of...

+ Read the Article

Morphotek and Protein Design Labs Announce Broad, Multi-Year Research Cross-License and Commercialization Agreement

July 19, 2004

Morphotek Inc. and Protein Design Labs, Inc. (PDL) (Nasdaq: PDLI) today announced a broad, multi-year research and commercialization agreement,...

+ Read the Article

Go to Page: 1 2

Results per page 10 25 50